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ABSTRAK
Latar belakang: glikokaliks usus berperan pada patogenesis translokasi bakteri penyebab sepsis yang 
berasal dari infeksi intraabdomen. Kondisi ini rentan terjadi pada golongan darah tertentu. Namun, sejauh ini 
belum diketahui hubungan antara glikokaliks usus pada golongan darah tertentu dengan infeksi intraabdomen. 
Penelitian ini bertujuan mengetahui kondisi glikokaliks usus pada sepsis intraabdomen pada golongan darah 
tertentu. Metode: penelitian deskriptif melibatkan subjek infeksi intraabdomen yang menjalani laparotomi. Sampel 
berupa spesimen usus. Dilakukan pengukuran ekspresi glikokaliks usus dengan metode ELISA menggunakan 
antigen golongan darah (A dan B). Data ekspresi pada sekretor dianalisis menggunakan uji Kolmogorov–Smirnov 
dilanjutkan dengan komparasi parametrik menggunakan ANOVA dan uji–t. Hasil: terdapat 32 subjek dengan infeksi 
intraabdomen yang diteliti pada studi ini. Seluruhnya berstatus sekretor serta mengeskpresikan antigen A dan B 
dengan kuat. Tidak ada perbedaan antara infeksi intraabdomen dengan komplikasi maupun tanpa komplikasi. 
Golongan darah O merupakan golongan darah yang dominan pada subjek (43,8%). Eschericia coli merupakan 
mikroba yang paling sering didapatkan (61,3%). Kesimpulan: penelitian ini menunjukkan tidak terjadi kerusakan 
glikokaliks pada usus pasien sepsis akibat infeksi intraabdomen.
Kata kunci: glikokaliks, infeksi intraabdomen, golongan darah.
ABSTRACT
Background: intestinal glycocalyx plays a role in bacterial translocation as the pathogenesis sepsis derived 
from intra-abdominal infections that vulnerable in certain blood types. However, the link between intestinal 
glycocalyx in specific types of blood groups and abdominal infections remains unknown. This study aims to find 
out the condition of intestinal glycocalyx in certain blood types with intraabdominal sepsis. Methods: descriptive 
study involved subjects with intraabdominal infections who underwent laparotomy. Samples are in the form of 
intestinal specimens. The measurement of intestinal glycocalyx proceeded by the ELISA method using blood group 
antigens (A and B). Expression data on the secretors were analyzed using the Kolmogorov – Smirnov test followed by 
parametric comparisons using ANOVA and t-tests. Results: there were 32 subjects with intra-abdominal infections 
studied in this study. All of them are secretors and express A and B antigens strongly. We found no difference between 
intraabdominal infections in those with complications or without complications. Blood type O is a predominant 
blood type found (43.8%). Escherichia coli is the most commonly found microbe in the culture (61.3%). Conclusion: 
this study shows there is no disrupted intestinal glycocalyx of sepsis patients caused by intraabdominal infection.
Keywords: glycocalyx, intraabdominal infection, blood type.
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INTRODUCTION
In the pathogenesis of gut-derived 
(abdominal) sepsis (recently attributed to 
intraabdominal infection), there are two main 
problems encountered and addressed in the clinical 
practice. The first issue is the phenomenon of 
bacterial translocation. Intraabdominal infection 
following gut perforation (or, complicated 
intraabdominal infections, cIAI) is a logical 
consequence. However, in the non–perforated 
viscus (non-complicated intraabdominal 
infections, or simply intraabdominal infections, 
IAI) – known as bacterial translocation – remains 
a mystery that needs more evidence.1–3 Recent 
studies showed that disrupted tight junctions 
that play an essential role in maintaining the 
intestinal mucosal barrier is responsible for the 
translocation.
The second issue is sepsis that identified in 
patients with blood type O of the ABO blood 
typing system. Studies showed that blood 
group O is prone to a particular disease while 
the other blood group not. Our preliminary 
study showed that sepsis develops in subjects 
with blood group O comprise of 46.69% out 
of 213 subjects diagnosed as complicated 
intraabdominal infections. In contrast, blood type 
A was 24.66%, and blood group B 26.87%.4 The 
phenomenon may clearly describe through the 
better knowledge of identified blood type antigen 
in the tissues other than blood cells (namely, 
secretor), using the blood typing system of the 
non–ABO system. The essential secretor of the 
blood type is glycocalyx of the gastrointestinal 
tract, as well as intestinal mucosa. Glycocalyx 
has a core peptide that binds the amino acid 
residues to the host’s glycans.5 The core 
peptide comprises either glycosylation–O that 
binds oxygen or glycosylation–N that binds 
other amino acids. The core peptide is found 
differently in each blood group.6 This distinctive 
characteristic leads to different susceptibility to 
certain conditions, including sepsis.7
While disintegrated endothelial glycocalyx 
paralleled to endothelial dysfunction found in 
sepsis, the course of intestinal glycocalyx remains 
unclear. To find out the answer, we investigated 
the glycocalyx in the intestinal mucosa in specific 
blood types in those diagnosed as intraabdominal 
infection (both in IAI and cIAI).
METHODS
The investigation proceeded in intestinal 
and blood specimens taken from subjects who 
diagnosed with an intraabdominal infection that 
underwent a surgical procedure in 2017. The 
diagnosis based on the findings: sepsis syndrome 
with GI perforation (cIAI) and with no perforation 
(IAI). Primary peritonitis, particularly abdominal 
tuberculosis, and those who are not the candidate 
for gut resection, and pediatrics excluded. The 
subjects enrolled consecutively as he/she agreed 
to be enrolled and signed the consent. The 
subjects’ characteristics, namely, age, gender, 
and diagnosis recorded. Blood specimens taken 
for some tests, particularly blood typing and 
peripheral blood count. Intraoperatively, gut 
specimens taken for investigation purposes — 
the samples subjected to mucin analysis for the 
expression of antigen A and B of blood group and 
bacterial culture to find out the microbial pattern.
Intestinal mucosa scraped and subjected to 
the investigation for the concentration of protein 
in glycocalyx. For ELISA purposes, we used anti 
A serum (Blood Group A Antigen Monoclonal 
Antibody, Human, Thermo Fisher, catalog HE–
193) and anti B serum (Blood Group B Antigen 
Monoclonal Antibody, Human, Thermo Fisher, 
catalog 89–F) and secondary antibody Goat 
anti–Mouse IgG (H+L) Secondary Antibody, 
HRP (Thermo Fisher, catalog 31430). Antigen 
expression on ELISA expressed in % intensity 
with reference of ABO blood group (transferase A, 
alpha 1–3–N–acetylgalactosaminyltransferase; 
transferase B, alpha 1–3–galactosyltransferase) 
of a homosapiens is 0.472813 (data Glycocalyx 
gene set).8
Data descriptively presented in two categories 
i.e., subjects with perforation and those not. The 
analysis preceded with a distribution test for 
numerical one using Kolmogorov Smirnov, a 
normal distribution defined as p-value >0.05. 
Binary data expressed in mean (SD) and 
categorical data presented in the table describing 
the frequency in percentage. Statistical analysis 
proceeded using a parametric compare of two 
means, namely ANOVA and non–parametric 
t-test.
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The committee of ethics Faculty of Medicine, 
Universitas Indonesia approved the study 
No.104/UN.F1/ETIK/2017 and the permission 
to conduct a study from Research Bureau of 
dr. Cipto Mangunkusumo General Hospital 
No.LB.02.01/X.2/66/2017.
RESULTS
Thirty–two subjects met the criteria enrolled 
in the study. All subjects treated empirically using 
intravenous aminoglycoside (namely gentamycin 
sulfate 80 mg b.i.d.) and metronidazole 1,500 
mg b.i.d. Subjects’ characteristics presented in 
Table 1.
found was Escherichia coli (19 subjects, 61.3%), 
Klebsiella pneumonia (5 subjects, 15.2%), 
Pseudomonas aeruginosa (2 subjects, 6.1%) 
Bacteroides fragilis (2 subjects, 6.1%), and 
Acinetobacter (1 subject, 3%). Besides, Candida 
albicans also found (2 subjects, 6.1%). Bacterial 
growth on the disc found in both cIAI (11 
subjects, 35.48%) and IAI (21 subjects, 67.74%). 
The difference between the two groups showing 
p = 0.119 CI 95% (-0.373-3.145).
Table 1. Subjects’ characteristics in the study (n = 32)
Demographic characteristics Total
Gender*, n (%)
 - Males 18 (56.2)
 - Females 14 (43.8)
Age (mean (SD)), years  52.3 (12.7)
Blood type*, n (%)
 - A 10 (31.2)
 - B 8 (25.0)
 - AB 0 (0.0)
 - O 14 (43.8)
Blood tests, mean (SD), cells/mm3
Leukocytes 15,223 (5,702)
Platelet 343,748 (163,634)
In the pathology point of view, GI infection, 
and the bowel obstruction found of most. The 
abdominal pathology both of GI– and non–GI 
origin presented in Table 2.
Bacterial culture (n = 31) were monomicrobial 
(7 subjects, 22.6%) and polymicrobial (24 
subjects, 77.4%) with the commonest bacteria 
Table 2. Intraabdominal pathology in the study (n = 32)
Abdominal 
pathology n (%)
 - GI origin 29 (90.6)
 - Gut 
perforation 
(cIAI)






21 (65.6) GI obstruction
 - Non–GI origin 3 (9.4) Perforated uterus
Pelvic abscess
Table 3. Expression of antigen A and antigen B in the 
study (n = 32)
Antigen expression P value
Normal 0.472813 (Glycocalyx gene set)
Antigen A, mean (SD) 2.33 (1.374) 0.467
Antigen B, mean (SD) 1.77 (1.334)
On the study of antigen expression (n = 32), 
namely antigen A (using anti–A serum) and 
antigen B (using anti–B serum), all subjects 
(100%) expressed both antigens; denoting all 
subjects were the secretors.
In the study, we found both antigen A and 
B were strongly expressed in most subjects (n 
= 32); indicating the oligosaccharide complex 
constructing the glycans was intact. Using 
ANOVA test proceeded to find out the difference 
between cIAI (n = 11) and IAI group (n = 21), 
we found p = 0.130 for antigen A and p =  0.250 
for antigen B; although box–whisker plot graphic 
showing the antigen expression in cIAI group 
a little bit stronger than those of IAI subjects 
(Figure 1).
Using independent samples test, we found 
there was no significant correlation of antigen A 
and B with cIAI and IAI; there’s no significant 
difference found.
Table 4. Antigen expression between cIAI and IAI
Group n mean (SD) P value
Antigen A
 - cIAI 11 1.5435 (0.59473) 0.130
 - IAI 21 1.2928 (0.32272)
Antigen B
 - cIAI 11 1.4246 (0.45230) 0.250
 - IAI 21 1.2775 (0.26075)
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DISCUSSION
The important findings in the study never 
been reported. Firstly, strong expression of 
antigen means an intact glycocalyx found both 
in IAI group (representing the theory of bacterial 
translocation) and perforated group as well. 
Secondly, using immune enzyme method we 
were unable to identify tissue blood type, but 
the secretor. In the study we found the dominant 
blood type in intraabdominal infection was 
blood type O, and the dominant bacteria found 
to translocated Escherichia coli, which is the 
commensal bacteria in the GI.
A study showed disrupted endothelial 
glycocalyx in sepsis, which identified through 
an investigation under hematoxylin-eosin stained 
specimens.9,10 There is plenty of research that 
showed disrupted endothelial glycocalyx in 
sepsis, including those correlated to the fluid 
management in sepsis.10 However, the intestinal 
glycocalyx has distinctive characteristics to 
endothelial. The mucin domain of the glycocalyx 
integrates with the deeper mucus layer on the 
mucosal surface and interacts with the bacterial 
residence, i.e., commensal bacteria. This deeper 
mucus layer contains mucin (produce of Goblet 
cells), and antimicrobial peptide (produce of 
Paneth cells), together with commensal bacteria, 
protects against pathogenic bacteria.11 It is 
known that the peptidoglycans of the glycocalyx 
consist of core peptides where the amino acids 
residues bound to glycans in two types, namely 
oxygen–linked glycosides (or, O–glycosylation) 
or N–glycosides (or, N–glycosylation) which 
are found differently in each blood type.12 
This specific characteristic leading to different 
susceptibility to a certain disease,13 including 
sepsis. Glycans are the contact site of microbes 
to the host cell, and the microbes take the energy 
required for metabolic activity, to grow and 
develop.7 The interaction between microbes and 
host proceeds in glycans that linked to O (namely, 
O–linked glycans)12 that contact to lectins in 
bacteria (hemagglutinins, ligands, adhesins).14 
The secrets (enzymes) released by the bacteria 
were able to modify glycosylated glycans in the 
mucin bound the ligands, and uptake and utilizes 
glucose for the microbial metabolic purposes. 
The interaction between microbes and mucus 
layers allowing a prolonged colonization.15
Normally, those of pathogenic remain in 
the superficial layer. However, changes in the 
luminal atmosphere such as antibiotics let the 
pathogenic invades the deeper layer.16,17 The 
flagella, the representative of microbial virulence 
contact to the glycocalyx. This contact is leading 
to disruption of glycocalyx results in a defect 
of signals transducing to the epithelial cell-to-
cell junctions. The molecules of the junction 
found disassembled, and the barrier is no longer 
maintained; formerly attributed to intestinal 
hyperpermeability. The micro molecules may 
migrate across the barrier.18,19
The above paragraphs explain the bacterial 
translocation focused on bacterial virulence, 
as many studies do. However, to date, the 
Figure 1. Box–Whisker plot graphic showing antigen expression in IAI and cIAI group. It is 
shown that the expression in the cIAI group is slightly stronger than IAI even though outliers 
were found in both of groups; statistically, this difference was not significant.
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pathophysiology of bacterial translocation 
remains unclear. Most believe it as a phenomenon 
rather than a true pathology.20 In addition to 
limited study focused on the exact mechanism of 
bacterial translocation that remain scanty, studies 
on intraabdominal sepsis continue focused on 
the virulence of various bacteria, the microbial 
resistance, and the effort to find out the superior 
antibiotic.21 One may have difficulty to explain 
how the bacteria may spread across the barrier 
with an intact glycocalyx.
There was a thought that glycocalyx of 
the intestinal mucosa in those of blood type O 
recognizes the antigens of the intestinal microbes 
let the microbes crossing the mucosal barrier with 
no host’s immune response. Whereas, when the 
antigen is not recognized, then the inflammatory 
response may lead to an excessive one, as found in 
the sepsis, which is destructive. To this thinking, 
we carried out the study focused on blood types 
approach. Glycans associated O referred to the 
structure rolled as the secretor of blood types. 
Both of antigen A and antigen B expressed on 
glycocalyx of intestinal mucosa of the secretor 
and blood group AB. Otherwise, these antigens 
not expressed in non–secretor and blood group 
O.22 The critical thinking is to distinguish blood 
group O to the non–secretor in non–expressed 
antigens; however, a more evidence is required. 
Our findings showed these antigens expressed 
in all subjects (100%) denoting all these 
subjects were the secretor, while the previous 
study showed only 70% of the population.23,24 
Theoretically, the carbohydrate-based antigens 
that have been identified as histo–blood group 
antigens (HBGA), blood group ABH and Lewis 
antigen also expressed in red blood cells are 
also expressed in other cells.25 Those other cells 
attributed as the secretor. Known secretors are 
the epithelium and endothelium. All epithelium 
throughout the body is the secretor, except the 
epithelium covering the cerebrospinal fluid. The 
last-mentioned epithelium found in the form of 
soluble oligosaccharides. Various pathogens use 
histo–blood groups antigen to be attached to 
the host cells. Studies show that this pathogen–
HBGA relationship promotes the different 
antigens currently known.24,25 Each individual 
has a variety of active glycosyltransferases. This 
variation is leading to a different oligosaccharide 
expression in the tissue. Among the epithelial of 
rolled as the secretors, mucin–coated glycocalyx 
in the GI epithelium known to be the most HBGA 
contained HBGA. The study of Marionneau 
(2000) showed that the H antigen in the blood 
group ABH, which is a characteristic possessed 
by blood group O (of the ABO blood group 
system), might change antigen A or B antigen 
through the role of glycosyltransferases A or 
B. ABH and antigen precursors were able to let 
fucosylated of GlcNAc (glycans) and forming 
Lewis antigen. Fucosyltransferase secretor/
FUT2 (small intestines) will be added resembling 
fucose secretor. This enzyme found in the 
secretors.26
In this study, all subjects were the secretor 
and exposed to intraabdominal infection. The 
infection was proven by the evidence of growing 
Escherichia coli (61.3%) in culture media 
taken from the peritoneum; beyond the lumen. 
This evidence, however, should be elaborated 
and critically appraised. Firstly, this finding 
did not eliminate the possibility that those of 
non–secretor is free from a potential to have an 
intraabdominal infection, because there were 
all the secretor has no control in this study. 
Secondly, those with blood O type were not 
the only ones who experienced intraabdominal 
infection, even though those with O type were 
found dominant (43.8%).
Investigation using this immune enzyme 
method is different from the current qualitative 
procedure using hemagglutination to identify 
blood type in tissues (i.e., secretors).8,27 
The technique is quite challenging. Despite 
encountering optimation procedures that 
took plenty of time, detection of the antigen 
expression referred to challenging one, because 
any value regarding the standard threshold 
should be obtained and set as the reference point.8 
A total of thirty–two subjects showing a strong 
expression (mean 1.374 and 1.77 for antigen A 
and B, respectively) or in another word 2.9 times 
(antigen A) and 3.7 times (antigen B) to normal.
The small-sized and inequality of samples 
was the limitation of the study; good candidates 
unwilling to be enrolled in the study; no resection 
indicated was the characteristic of problems 
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in surgical research. Other limitations in this 
study, including 1) the blood group test that 
not carried out simultaneously, even though the 
same serum used; thus, might lead to a bias. 
2) the study on saliva using the same antigen, 
which proposed early, was found unable to be 
proceeded due to constraining. Finally, no study 
on histomorphology carried out. On the other 
hand, the authors believe that this study, which 
focused on glycocalyx on the intestinal mucosa, 
has not been ever studied, expected to encourage 
future studies.
CONCLUSION
In intraabdominal infection, the glycocalyx 
was intact showing bacterial translocation 
without disrupting the barrier. However, the 
link with blood type could not be explained in 
this study.
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